Evidence map›Paper›PMID 38341194›Full record

ReviewRMD open2024

Metabolic and molecular imaging in inflammatory arthritis.

Rita Noversa de Sousa, Koray Tascilar, Giulia Corte, Armin Atzinger, Ioanna Minopoulou, Sarah Ohrndorf, Maximilian Waldner, Christian Schmidkonz, Torsten Kuwert, Ferdinand Knieling and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Emerging Landscape ofACS pharmacology & translational science · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Rita Noversa de SousaDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Koray TascilarDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-8109-826X
Giulia CorteDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Armin AtzingerDepartment of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Ioanna MinopoulouDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Sarah OhrndorfDepartment of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-5943-4688
Maximilian WaldnerDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Christian SchmidkonzDepartment of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Torsten KuwertDepartment of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Ferdinand KnielingDepartment of Pediatrics and Adolescent Medicine, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Arnd KleyerDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Andreas RammingDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Georg SchettDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
David SimonDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0001-8310-7820
Filippo FagniDepartment of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany Filippo.Fagni@uk-erlangen.de.ORCID 0000-0002-6122-0774
Friedrich-Alexander-Universität Erlangen-Nürnberg · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that metabolic shifts and tissue remodelling precede the development of visible inflammation and structural organ damage in inflammatory rheumatic diseases such as the inflammatory arthritides. As such, visualising and measuring metabolic tissue activity could be useful to identify biomarkers of disease activity already in a very early phase. Recent advances in imaging have led to the development of so-called 'metabolic imaging' tools that can detect these changes in metabolism in an increasingly accurate manner and non-invasively.Nuclear imaging techniques such as

Indexed as

ArthritisHumansInflammationMolecular ImagingPositron-Emission TomographyTomography, X-Ray ComputedArthritisArthritis, RheumatoidInflammationLipidsUltrasonography

Identifiers

PMID38341194
PMCPMC10862311
OpenAlexW4391719480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.